Last reviewed · How we verify

NCT03586323

Awake Fiber Optic Intubation (AFOI) and Laryngeal Nervous Block

Status unknown NA Last updated 17 July 2018
What this trial tests

NA trial testing superior laryngeal nerve block with lidocaine in Airway Complication of Anesthesia in 40 participants. Status unknown.

Timeline
15 April 2018
Primary endpoint
24 July 2018
1 August 2018

Quick facts

Lead sponsorUniversity of Roma La Sapienza
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment40
Start date15 April 2018
Primary completion24 July 2018
Estimated completion1 August 2018
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

University of Roma La Sapienza

Who can join

18 and older, any sex, with Airway Complication of Anesthesia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Oncologic laryngeal surgery is a challenge for anesthesiologists and awake fiberoptic intubation (AFOI) is mandatory to manage difficult airways and prevent the Can't Intubate Can't Oxigenate (CICO). Laryngospasm and oversedation are dangerous complication often life-threatening in this kind of patient. Superior laryngeal nerve block (SLNB) could be an alternative technique useful to reduce risks and to improve patient comfort. Aim of this study is to assess the procedural comfort of the SLNB during AFOI, in a population of patients suffering from severe airways obstruction undergoing pharyngeal-laryngeal surgery. 40 patients will be randomized in two groups(20 for each group) and will be treated with continuous infusion of remifentanil, topic anesthesia of the base of the tongue and intercricoid block. In group A will be associated the SLNB; placebo will be administered in group B.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Airway Complication of Anesthesia

Currently open trials in the same condition.

Other University of Roma La Sapienza trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03586323.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing